• Mon espace de travail
  • Aide IRIS
  • Par Publication Par Personne Par Unité
    • English
    • Français
  • Se connecter
Logo du site

IRIS | Système d’Information de la Recherche Institutionnelle

  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
UNIL
  • English
  • Français
Se connecter
IRIS
  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
  • Mon espace de travail
  • Aide IRIS

Parcourir IRIS

  • Par Publication
  • Par Personne
  • Par Unité
  1. Accueil
  2. IRIS
  3. Publication
  4. Influenza in solid organ transplant recipients: epidemiology, management, and outcomes.
 
  • Détails
Titre

Influenza in solid organ transplant recipients: epidemiology, management, and outcomes.

Type
synthèse (review)
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Expert Review of Anti-infective Therapy  
Auteur(s)
Mombelli, M.
Auteure/Auteur
Kampouri, E.
Auteure/Auteur
Manuel, O.
Auteure/Auteur
Liens vers les personnes
Manuel, Oriol  
Mombelli, Matteo  
Kampouri, Eleftheria Evdokia  
Liens vers les unités
Maladies infectieuses  
Centre de transplantation d'organes  
ISSN
1744-8336
Statut éditorial
Publié
Date de publication
2020-02
Volume
18
Numéro
2
Première page
103
Dernière page/numéro d’article
112
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Introduction: In solid organ transplant (SOT) recipients, influenza is associated with significant morbidity, including high hospital admission and mortality rates. Influenza may also impair allograft outcomes, in particular in lung transplant recipients. Early treatment with antivirals and seasonal vaccination contribute to reduce influenza-associated morbidity in this population.Areas covered: We selected a number of publications by searching into Pubmed to review the epidemiology, clinical presentation, outcomes, and management of influenza in SOT recipients. We discuss current treatment options and recent advances in the development of new vaccination strategies.Expert opinion: Our review showed that despite recent studies addressing the current epidemiology of influenza in SOT recipients, data in this population remain sparse. Large international multi-season cohort studies should better describe the actual burden of influenza. Although oseltamivir is an effective drug and should be given to all SOT recipients, the use of novel antivirals and combination therapies need to be tested prospectively in this population. Finally, recent studies aiming to improve the immunogenicity of influenza vaccine in SOT recipients showed promising results, in particular with the use of high-dose vaccines and booster-dose. Clinical trials using clinical endpoints would be important to foster the introduction of these vaccines in the routine clinical practice.
Sujets

Allograft dysfunction...

Antiviral therapy

Influenza

Transplant Recipients...

Vaccine

PID Serval
serval:BIB_3B8DD16D8B92
DOI
10.1080/14787210.2020.1713098
PMID
31910344
WOS
000507847800001
Permalien
https://iris.unil.ch/handle/iris/97752
Date de création
2020-01-10T13:39:13.787Z
Date de création dans IRIS
2025-05-20T18:21:54Z
  • Copyright © 2024 UNIL
  • Informations légales